Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strategic Directions International (SDi) is a leading business intelligence and market research firm specializing in the analytical and life science instruments industry. The company provides specialized data, strategic consulting, and market analysis to manufacturers, service providers, and investors within the scientific technology sector. SDi is widely recognized for its flagship publication, Instrument Business Outlook (IBO), which tracks the financial performance and technological trends of the global analytical instrument market. Their expertise encompasses a broad range of technologies, including chromatography, mass spectrometry, molecular biology tools, and lab automation. Founded in 1981 and headquartered in Los Angeles, SDi was acquired by BioInformatics Inc. in 2014 and now operates as a core brand under the Science and Medicine Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strategic Directions International.